Inogen (NASDAQ:INGN) versus Jin Medical International (NASDAQ:ZJYL) Financial Analysis

Jin Medical International (NASDAQ:ZJYL) and Inogen (NASDAQ:INGN) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability.

Analyst Ratings

This is a breakdown of current ratings and target prices for Jin Medical International and Inogen, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jin Medical International	0	0	0	0	0.00
Inogen	0	2	0	0	2.00

Inogen has a consensus price target of $7.00, suggesting a potential upside of 21.74%. Given Inogen’s stronger consensus rating and higher possible upside, analysts clearly believe Inogen is more favorable than Jin Medical International.

Valuation & Earnings

This table compares Jin Medical International and Inogen”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jin Medical International	$23.50 million	5.50	$3.68 million	N/A	N/A
Inogen	$335.71 million	0.46	-$102.45 million	($1.15)	-5.00

Jin Medical International has higher earnings, but lower revenue than Inogen.

Profitability

This table compares Jin Medical International and Inogen’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Jin Medical International	N/A	N/A	N/A
Inogen	-15.89%	-27.38%	-16.77%

Volatility & Risk

Jin Medical International has a beta of 12.24, meaning that its share price is 1,124% more volatile than the S&P 500. Comparatively, Inogen has a beta of 1.63, meaning that its share price is 63% more volatile than the S&P 500.

Insider & Institutional Ownership

89.9% of Inogen shares are owned by institutional investors. 1.5% of Inogen shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Jin Medical International beats Inogen on 6 of the 11 factors compared between the two stocks.

About Jin Medical International

Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. is a subsidiary of Jolly Harmony Enterprises Limited.

About Inogen

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.